The CDR2L Polyclonal Antibody is a vital tool for researchers studying the CD300A protein, a key player in immune regulation. This antibody, produced in rabbits, exhibits high reactivity with human samples and has been validated for use in Western blot applications. By binding specifically to CD300A, this antibody enables accurate detection and analysis in various cell types, making it an excellent choice for studies in immunology and cancer research.CD300A, also known as an immune inhibitory receptor, is crucial in maintaining immune homeostasis by regulating inflammation and suppressing allergic reactions.
Its role in immune response modulation has made it a valuable target for research into diseases such as cancer, autoimmune disorders, and chronic inflammatory conditions. Understanding the functions of CD300A is essential for the development of therapies that can manipulate or harness immune function in these disease contexts.
Western Blot. Positive WB detected in: SH-SY5Y whole cell lysate. All lanes: CDR2L antibody at 7.1µg/ml. Secondary. Goat polyclonal to rabbit IgG at 1/50000 dilution. Predicted band size: 54 kDa. Observed band size: 54 kDa.
IHC image of PACO57692 diluted at 1:200 and staining in paraffin-embedded human small intestine tissue performed on a Leica BondTM system. After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30min at RT. Then primary antibody (1% BSA) was incubated at 4°C overnight. The primary is detected by a biotinylated secondary antibody and visualized using an HRP conjugated SP system.
Synonyms:
Cerebellar degeneration-related protein 2-like (Paraneoplastic 62 kDa antigen), CDR2L, HUMPPA
UniProt Protein Function:
CDR2L: Belongs to the CDR2 family.Protein type: Unknown functionChromosomal Location of Human Ortholog: 17q25.1
